KMPH Stock Price, News & Analysis
Company Description
KMPH (NASDAQ: KMPH) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $200.5M.
KMPH stock has declined 2.0% over the past year.
This page provides a comprehensive overview of KMPH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
KMPH (KMPH) stock. Over the past 12 months, the stock has lost 2.0%. At a market capitalization of $200.5M, KMPH is classified as a micro-cap stock with approximately 34.5M shares outstanding.
Latest News
KMPH has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings. View all KMPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
KMPH Company Profile & Sector Positioning
KMPH (KMPH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing KMPH often look at related companies in the same sector, including Faron Pharmaceuticals Oy (FPHAF), Genfit S.A. (GNFT), Tiziana Life Sciences Ltd Com (TLSA), Tenaya Therapeutics, Inc. (TNYA), and COGNITION THERAPEUTICS INC (CGTX). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KMPH's relative position within its industry.